Cite
HARVARD Citation
Ajayi, O. et al. (2018). After metformin, what is the best oral agent for use in patients with type 2 diabetes without comorbidities?. Evidence-based practice. 21 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ajayi, O. et al. (2018). After metformin, what is the best oral agent for use in patients with type 2 diabetes without comorbidities?. Evidence-based practice. 21 (4), p. . [Online].